More on Perkin Elmer (PKI): Q3 beats across the board on strong revenue growth out of its...

|By:, SA News Editor

More on Perkin Elmer (PKI): Q3 beats across the board on strong revenue growth out of its human-health focused segment. Net profit declined 19% however, due largely to lower contributions from businesses that the company has sold. For FY12, the company raises its per-share earnings estimate to $2.05 to $2.07, up from its prior estimate for $2 to $2.05, and reiterated its forecast for organic revenue growth.